期刊文献+

比较3种不同类药物对儿童持续性变应性鼻炎症状评分的改善作用 被引量:24

The effects of three different medications on persistent allergic rhinitis in children
下载PDF
导出
摘要 目的:比较鼻内糖皮质激素、白三烯受体拮抗剂和第2代口服抗组胺药对儿童变应性鼻炎(AR)症状评分和生活质量评分的改善作用,探讨鼻炎的个体化药物治疗方案。方法:将186例年龄6.14岁的中、重度持续性AR患儿,随机分入布地奈德(BUD)组、孟鲁司特(MON)组和氯雷他定(LORA)组。BUD组使用布地奈德鼻喷剂256μg/d,MON组每晚口服孟鲁司特5mg,LORA组每日口服氯雷他定片5mg或10mg。进行鼻炎症状评分和鼻结膜炎生命质量问卷(RQLQ)评分,评分越低症状越轻。结果:治疗4周.三组比较鼻炎症状总评分在BUD组最低(F=2.977,P〈0.05)。鼻塞症状评分BUD组改善最显著(χ2=6.488.P〈0.01),而MON组鼻塞评分亦显著低于LORA组(P〈0.01)。流涕和喷嚏评分在LORA组和BUD组改善明显.三组比较差异有统计学意义(χ2=4.176和5.806,P〈0.01)。咽痒评分在MON组和BUD组显著低于LORA组(P〈0.01)。同时BUD组RQLQ总分和RQLQ鼻部症状评分显著低于其他两组(P〈0.05)。MON组眼痒症状评分和RQLQ眼部症状评分,数值上均低于其他两组,但差异均未达显著界值(P〉0.05)。结论:布地奈德对鼻炎的总体症状和鼻塞改善更具优势;氯雷他定对喷嚏和流涕效果突出,但对鼻塞效果差;而孟鲁司特对咽瘁和鼻塞的效果优于氯雷他定,对眼部症状亦有一定的优势。 Objective To compare the effects of intranasal corticosteroid, leukotriene receptor antagonist, and oral antihistamine on persistent allergic rhinitis (AR) in children and explore invidivualized therapy for child AR. Methods 186 children (6-14years) with moderate to severe persistent AR were evenly randomized into three groups treated by nasal budesonide (BUD), montelukast (MON), loratadine (LORA). The thress groups were compared in terms of symptoms scores and scores by rhinoconjunctivitis quality of life questionnaire (RQLQ). Results After 4 weeks therapy, nasal obstruction scores were most significantly improved in BUD group (P 〈 0.01 ), followed by MON group and then LORA group. The scores on rhinoxxhea and sneezing in LORA and BUD group were more effectively improved compared to MON group (P 〈 0.01 ). The scores on throat itching in BUD group and MON group were lower than in LORA group (P 〈 0.01 ). The total scores by RQLQ and nasal RQLQ were significantly improved in BUD group (all P 〈 0.05). The scores on eye itching and eye RQLQ in MON group were insignificantly lower, than the other two groups (both P 〉 0.05). Conclusion Nasal budesonide is a superior agent for improving nasal obstruction and the general symptoms. Loratadine is more effective in reducing rhinorrhea and sneezing. Montelukast has better results in reducing throat itching and some advantage in reducing eyes symptoms.
出处 《实用医学杂志》 CAS 北大核心 2014年第2期219-221,共3页 The Journal of Practical Medicine
基金 广东省科技厅资助项目(编号:2010B031600149)
关键词 变应性鼻炎 儿童 鼻内激素 白三烯受体拮抗剂 抗组胺药 Children Allergic rhinitis Intranasal cortieosteroids Leukotriene receptor antagonists Antihistamines
  • 相关文献

参考文献9

  • 1Sardana N, Santos C, Lehman E, et al. A comparison of intranasal corticosteroid, leukotriene receptor antagonist, and topical antihistamine in reducing symptoms of perennial allergic rhinitis as assessed through the Rhinitis Severity Score [ J ]. Allergy Asthma Proc, 2010, (1) :5-9. 被引量:1
  • 2中华耳鼻咽喉头颈外科杂志编委会鼻科组 中华医学会耳鼻咽喉头颈外科学分会鼻科学组.变应性鼻炎诊断和治疗指南(2009年武夷山)[J].中华耳鼻咽喉头颈外科杂志,2009,44:977-978. 被引量:90
  • 3Camargos P, Ibiapina C, Lasmar L, et al. Obtaining concomitant control of allergic rhiaitis and asthma with a nasally inhaled corticostero [ J ]. Allergy, 2007,62 ( 3 ) : 310-316. 被引量:1
  • 4Juniper EF, Howland WC, Roberts NB, et al. Measuring quality of life in children with rhinoconjunctivitis [ J ]. J Allergy Clin Irmnunol, 1998,101(2 Pt 1) : 163-170. 被引量:1
  • 5Baraniuk JN. Pathogenesis of allergic rhinitis [ J ]. J Allergy Chn Immunol, 1997,99: S763-S772. 被引量:1
  • 6张艺.布地奈德鼻喷剂治疗儿童变应性鼻炎临床观察[J].实用医学杂志,2005,21(9):968-969. 被引量:10
  • 7A1 Suleimani YM, Dong Y, Walker MJ. Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs [ J ]. Pulm Pharmacol Ther, 2008,2 : 340-348. 被引量:1
  • 8Dayyat E, Serpero LD, Kheirandish-Gozal L, et al. Leukotriene pathways and in vitro adenotonsillar cell proliferation in children with obstructive sleep apnea [ J ]. Chest, 2009,135 (5) : 1142- 1149. 被引量:1
  • 9Lambiase A, Bonini S, Rasi G, et al. Montelukast, a leukotriene receptor antagonist, in vernal keratoconjunctivitis associated with asthma [ J ]. Arch Ophthalmol, 2003,121 (5) : 615-620. 被引量:1

二级参考文献1

共引文献98

同被引文献226

引证文献24

二级引证文献178

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部